Highland Capital Management Fund Advisors, L.P. Mirum Pharmaceuticals, Inc. Transaction History

Highland Capital Management Fund Advisors, L.P.

$846 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2019 Feb 14, 2020	SELL	$6.84 - $25.9 $68,400 - $259,000	-10,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$9.16 - $14.77 $91,600 - $147,700	10,000 New	10,000 $101,000

Others Institutions Holding MIRM

# of Institutions

193

Shares Held

54.1M

Call Options Held

177K

Put Options Held

167K

Frazier Life Sciences Management, L.P. Menlo Park, CA

6.57M
Shares

$312 Million
13.79% of portfolio
Janus Henderson Group PLC London, X0

4.48M
Shares

$213 Million
0.09% of portfolio
Eventide Asset Management, LLC Boston, MA

3.45M
Shares

$164 Million
2.37% of portfolio
Black Rock Inc. New York, NY

3.24M
Shares

$154 Million
0.0% of portfolio
Bvf Inc San Francisco, CA

3.08M
Shares

$146 Million
3.81% of portfolio

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.75B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.

Account